Continuing education lectures on adult glioblastoma to be held at all U.S. healthcare centers

Adult glioblastoma continues to be a difficult disease to treat, so healthcare professionals must have the most up-to-date information regarding optimal methods for diagnostic imaging and treatment of these tumors. Awareness of novel agents in clinical trials is also critical to providing the best care.

To address the need for current education on adult glioblastoma diagnosis and treatment, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a series of complimentary continuing education lectures at healthcare centers throughout the United States titled Current Perspectives in Adult Glioblastoma. This activity is supported by an educational grant from Merck.

Experts in neurology, neuro-oncology, and neurosurgery from leading medical institutions across the country will serve as faculty for this series, which is chaired by Marc C. Chamberlain, MD. Dr. Chamberlain is professor of neurology and neurological surgery and chief of the division of neuro-oncology at the University of Washington in Seattle.

Healthcare professionals can visit www.RMEI.com/GBlectures today to schedule a meeting at their institution.